RESUMEN
BACKGROUND & AIMS: Nonalcoholic steatohepatitis (NASH) is a complex disease involving both genetic and environmental factors in its onset and progression. We analyzed NASH phenotypes in a genetically diverse cohort of mice, the Hybrid Mouse Diversity Panel, to identify genes contributing to disease susceptibility. METHODS: A "systems genetics" approach, involving integration of genetic, transcriptomic, and phenotypic data, was used to identify candidate genes and pathways in a mouse model of NASH. The causal role of Matrix Gla Protein (MGP) was validated using heterozygous MGP knockout (Mgp+/-) mice. The mechanistic role of MGP in transforming growth factor-beta (TGF-ß) signaling was examined in the LX-2 stellate cell line by using a loss of function approach. RESULTS: Local cis-acting regulation of MGP was correlated with fibrosis, suggesting a causal role in NASH, and this was validated using loss of function experiments in 2 models of diet-induced NASH. Using single-cell RNA sequencing, Mgp was found to be primarily expressed in hepatic stellate cells and dendritic cells in mice. Knockdown of MGP expression in stellate LX-2 cells led to a blunted response to TGF-ß stimulation. This was associated with reduced regulatory SMAD phosphorylation and TGF-ß receptor ALK1 expression as well as increased expression of inhibitory SMAD6. Hepatic MGP expression was found to be significantly correlated with the severity of fibrosis in livers of patients with NASH, suggesting relevance to human disease. CONCLUSIONS: MGP regulates liver fibrosis and TGF-ß signaling in hepatic stellate cells and contributes to NASH pathogenesis.
Asunto(s)
Enfermedad del Hígado Graso no Alcohólico , Animales , Humanos , Ratones , Cirrosis Hepática/genética , Factor de Crecimiento Transformador beta , Factores de Crecimiento Transformadores , Proteína Gla de la MatrizRESUMEN
Vehicle fault detection and diagnosis (VFDD) along with predictive maintenance (PdM) are indispensable for early diagnosis in order to prevent severe accidents due to mechanical malfunction in urban environments. This paper proposes an early voiceprint driving fault identification system using machine learning algorithms for classification. Previous studies have examined driving fault identification, but less attention has focused on using voiceprint features to locate corresponding faults. This research uses 43 different common vehicle mechanical malfunction condition voiceprint signals to construct the dataset. These datasets were filtered by linear predictive coefficient (LPC) and wavelet transform(WT). After the original voiceprint fault sounds were filtered and obtained the main fault characteristics, the deep neural network (DNN), convolutional neural network (CNN), and long short-term memory (LSTM) architectures are used for identification. The experimental results show that the accuracy of the CNN algorithm is the best for the LPC dataset. In addition, for the wavelet dataset, DNN has the best performance in terms of identification performance and training time. After cross-comparison of experimental results, the wavelet algorithm combined with DNN can improve the identification accuracy by up to 16.57% compared with other deep learning algorithms and reduce the model training time by up to 21.5% compared with other algorithms. Realizing the cross-comparison of recognition results through various machine learning methods, it is possible for the vehicle to proactively remind the driver of the real-time potential hazard of vehicle machinery failure.
Asunto(s)
Conducción de Automóvil , Aprendizaje Profundo , Algoritmos , Redes Neurales de la Computación , Análisis de OndículasRESUMEN
The necessity of vehicle fault detection and diagnosis (VFDD) is one of the main goals and demands of the Internet of Vehicles (IoV) in autonomous applications. This paper integrates various machine learning algorithms, which are applied to the failure prediction and warning of various types of vehicles, such as the vehicle transmission system, abnormal engine operation, and tire condition prediction. This paper first discusses the three main AI algorithms, such as supervised learning, unsupervised learning, and reinforcement learning, and compares the advantages and disadvantages of each algorithm in the application of system prediction. In the second part, we summarize which artificial intelligence algorithm architectures are suitable for each system failure condition. According to the fault status of different vehicles, it is necessary to carry out the evaluation of the digital filtering process. At the same time, it is necessary to preconstruct its model analysis and adjust the parameter attributes, types, and number of samples of various vehicle prediction models according to the analysis results, followed by optimization to obtain various vehicle models. Finally, through a cross-comparison and sorting, the artificial intelligence failure prediction models can be obtained, which can correspond to the failure status of a certain car model and a certain system, thereby realizing a most appropriate AI model for a specific application.
RESUMEN
Inflammatory responses by the innate and adaptive immune systems protect against infections and are essential to health and survival. Many diseases including atherosclerosis, osteoarthritis, rheumatoid arthritis, psoriasis, and obesity involve persistent chronic inflammation. Currently available anti-inflammatory agents, including non-steroidal anti-inflammatory drugs, steroids, and biologics, are often unsafe for chronic use due to adverse effects. The development of effective non-toxic anti-inflammatory agents for chronic use remains an important research arena. We previously reported that oral administration of Oxy210, a semi-synthetic oxysterol, ameliorates non-alcoholic steatohepatitis (NASH) induced by a high-fat diet in APOE*3-Leiden.CETP humanized mouse model of NASH and inhibits expression of hepatic and circulating levels of inflammatory cytokines. Here, we show that Oxy210 also inhibits diet-induced white adipose tissue inflammation in APOE*3-Leiden.CETP mice, evidenced by the inhibition of adipose tissue expression of IL-6, MCP-1, and CD68 macrophage marker. Oxy210 and related analogs exhibit anti-inflammatory effects in macrophages treated with lipopolysaccharide in vitro, mediated through inhibition of toll-like receptor 4 (TLR4), TLR2, and AP-1 signaling, independent of cyclooxygenase enzymes or steroid receptors. The anti-inflammatory effects of Oxy210 are correlated with the inhibition of macrophage polarization. We propose that Oxy210 and its structural analogs may be attractive candidates for future therapeutic development for targeting inflammatory diseases.
Asunto(s)
Enfermedad del Hígado Graso no Alcohólico , Oxiesteroles , Animales , Apolipoproteínas E/metabolismo , Inflamación/metabolismo , Macrófagos/metabolismo , Ratones , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Oxiesteroles/metabolismo , Oxiesteroles/farmacología , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 4/metabolismoRESUMEN
The research describes the recognition and classification of the acoustic characteristics of amphibians using deep learning of deep neural network (DNN) and long short-term memory (LSTM) for biological applications. First, original data is collected from 32 species of frogs and 3 species of toads commonly found in Taiwan. Secondly, two digital filtering algorithms, linear predictive coding (LPC) and Mel-frequency cepstral coefficient (MFCC), are respectively used to collect amphibian bioacoustic features and construct the datasets. In addition, principal component analysis (PCA) algorithm is applied to achieve dimensional reduction of the training model datasets. Next, the classification of amphibian bioacoustic features is accomplished through the use of DNN and LSTM. The Pytorch platform with a GPU processor (NVIDIA GeForce GTX 1050 Ti) realizes the calculation and recognition of the acoustic feature classification results. Based on above-mentioned two algorithms, the sound feature datasets are classified and effectively summarized in several classification result tables and graphs for presentation. The results of the classification experiment of the different features of bioacoustics are verified and discussed in detail. This research seeks to extract the optimal combination of the best recognition and classification algorithms in all experimental processes.
Asunto(s)
Acústica , Algoritmos , Memoria a Largo Plazo/fisiología , Memoria a Corto Plazo/fisiología , Redes Neurales de la Computación , Animales , Anuros , Sonido , TaiwánRESUMEN
The metabolic syndrome is a cluster of conditions that increase an individual's risk of developing diseases. Being physically active throughout life is known to reduce the prevalence and onset of some aspects of the metabolic syndrome. Furthermore, previous studies have demonstrated that an individual's gut microbiome composition has a large influence on several aspects of the metabolic syndrome. However, the mechanism(s) by which physical activity may improve metabolic health are not well understood. We sought to determine if endurance exercise is sufficient to prevent or ameliorate the development of the metabolic syndrome and its associated diseases. We also analyzed the impact of physical activity under metabolic syndrome progression upon the gut microbiome composition. Utilizing whole-body low-density lipoprotein receptor (LDLR) knockout mice on a "Western Diet," we show that long-term exercise acts favorably upon glucose tolerance, adiposity, and liver lipids. Exercise increased mitochondrial abundance in skeletal muscle but did not reduce liver fibrosis, aortic lesion area, or plasma lipids. Lastly, we observed several changes in gut bacteria and their novel associations with metabolic parameters of clinical importance. Altogether, our results indicate that exercise can ameliorate some aspects of the metabolic syndrome progression and alter the gut microbiome composition.
Asunto(s)
Microbioma Gastrointestinal , Síndrome Metabólico/fisiopatología , Condicionamiento Físico Animal/métodos , Adiposidad , Animales , Glucosa/metabolismo , Hígado/metabolismo , Masculino , Síndrome Metabólico/metabolismo , Síndrome Metabólico/terapia , Ratones , Ratones Endogámicos C57BL , Mitocondrias Hepáticas/metabolismo , Receptores de LDL/genética , Receptores de LDL/metabolismo , CarreraRESUMEN
AIMS: Non-alcoholic steatohepatitis (NASH) is associated with increased overall morbidity and mortality in non-alcoholic fatty liver disease (NAFLD) patients. Liver fibrosis is the strongest prognostic factor for clinical outcomes, liver-related mortality and liver transplantation. Currently, no single therapy or medication for NASH has been approved by the U.S. Food and Drug Administration (FDA). Oxy210, an oxysterol derivative, displays the unique property of antagonizing both Hedgehog (Hh) and transforming growth factor-beta (TGF-ß) signalling in primary human hepatic stellate cells (HSC). We hypothesized that inhibition of both Hh and TGF-ß signalling by Oxy210 could reduce hepatic fibrosis in NASH. In this study, we examined the therapeutic potential of Oxy210 on NASH in vivo. METHODS: We examined the effect of Oxy210 treatment on Hh and TGF-ß pathways in HSC. The efficacy of Oxy210 on liver fibrosis was tested in a 'humanized' hyperlipidemic mouse model of NASH that has high relevance to human pathology. APPROACH AND RESULTS: We show that Oxy210 inhibits both Hh and TGF-ß pathways in human HSC and attenuates baseline and TGF-ß-induced expression of pro-fibrotic genes in vitro. Oral delivery of Oxy210 in food resulted in significant liver exposure and significantly reduced hepatic fibrosis in mice over the course of the 16-week study with no apparent safety issues. Additionally, we observed several benefits related to NASH phenotype: (a) reduced plasma pro-inflammatory cytokine and the corresponding hepatic gene expression; (b) reduced pro-fibrotic cytokine and inflammasome gene expression in the liver; (c) reduced apoptosis in the liver; (d) reduced hepatic unesterified cholesterol accumulation; and (e) reduced plasma total and unesterified cholesterol levels. CONCLUSIONS: Oxy210 effectively ameliorated hepatic fibrosis and inflammation and improved hypercholesterolemia in mice. Our findings suggest that Oxy210 and related analogues are a new class of drug candidates that may serve as potential therapeutics candidates for NASH.
Asunto(s)
Proteínas Hedgehog , Hipercolesterolemia , Animales , Proteínas Hedgehog/genética , Proteínas Hedgehog/metabolismo , Humanos , Cirrosis Hepática/etiología , Cirrosis Hepática/genética , Ratones , Transducción de Señal , Factor de Crecimiento Transformador beta/metabolismo , Estados UnidosRESUMEN
To elucidate the contributions of specific lipid species to metabolic traits, we integrated global hepatic lipid data with other omics measures and genetic data from a cohort of about 100 diverse inbred strains of mice fed a high-fat/high-sucrose diet for 8 weeks. Association mapping, correlation, structure analyses, and network modeling revealed pathways and genes underlying these interactions. In particular, our studies lead to the identification of Ifi203 and Map2k6 as regulators of hepatic phosphatidylcholine homeostasis and triacylglycerol accumulation, respectively. Our analyses highlight mechanisms for how genetic variation in hepatic lipidome can be linked to physiological and molecular phenotypes, such as microbiota composition.
Asunto(s)
Dieta Alta en Grasa/efectos adversos , Hígado Graso/genética , Glucosa/efectos adversos , Resistencia a la Insulina/genética , MAP Quinasa Quinasa 6/genética , Proteínas Nucleares/genética , Animales , Modelos Animales de Enfermedad , Hígado Graso/inducido químicamente , Hígado Graso/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Variación Genética , Lipidómica , Masculino , Ratones , Fosfatidilcolinas/metabolismo , Triglicéridos/metabolismoRESUMEN
BACKGROUND & AIMS: Liver fibrosis is a multifactorial trait that develops in response to chronic liver injury. Our aim was to characterize the genetic architecture of carbon tetrachloride (CCl4)-induced liver fibrosis using the Hybrid Mouse Diversity Panel, a panel of more than 100 genetically distinct mouse strains optimized for genome-wide association studies and systems genetics. METHODS: Chronic liver injury was induced by CCl4 injections twice weekly for 6 weeks. Four hundred thirty-seven mice received CCl4 and 256 received vehicle, after which animals were euthanized for liver histology and gene expression. Using automated digital image analysis, we quantified fibrosis as the collagen proportionate area of the whole section, excluding normal collagen. RESULTS: We discovered broad variation in fibrosis among the Hybrid Mouse Diversity Panel strains, demonstrating a significant genetic influence. Genome-wide association analyses revealed significant and suggestive loci underlying susceptibility to fibrosis, some of which overlapped with loci identified in mouse crosses and human population studies. Liver global gene expression was assessed by RNA sequencing across the strains, and candidate genes were identified using differential expression and expression quantitative trait locus analyses. Gene set enrichment analyses identified the underlying pathways, of which stellate cell involvement was prominent, and coexpression network modeling identified modules associated with fibrosis. CONCLUSIONS: Our results provide a rich resource for the design of experiments to understand mechanisms underlying fibrosis and for rational strain selection when testing antifibrotic drugs.
Asunto(s)
Tetracloruro de Carbono/toxicidad , Redes Reguladoras de Genes/efectos de los fármacos , Predisposición Genética a la Enfermedad , Cirrosis Hepática/inducido químicamente , Hígado/patología , Animales , Tetracloruro de Carbono/administración & dosificación , Modelos Animales de Enfermedad , Estudio de Asociación del Genoma Completo , Humanos , Inyecciones Intraperitoneales , Hígado/efectos de los fármacos , Cirrosis Hepática/genética , Cirrosis Hepática/patología , Masculino , Ratones , Sitios de Carácter CuantitativoRESUMEN
We studied sex differences in over 50 cardio-metabolic traits in a panel of 100 diverse inbred strains of mice. The results clearly showed that the effects of sex on both clinical phenotypes and gene expression depend on the genetic background. In support of this, genetic loci associated with the traits frequently showed sex specificity. For example, Lyplal1, a gene implicated in human obesity, was shown to underlie a sex-specific locus for diet-induced obesity. Global gene expression analyses of tissues across the panel implicated adipose tissue "beiging" and mitochondrial functions in the sex differences. Isolated mitochondria showed gene-by-sex interactions in oxidative functions, such that some strains (C57BL/6J) showed similar function between sexes, whereas others (DBA/2J and A/J) showed increased function in females. Reduced adipose mitochondrial function in males as compared to females was associated with increased susceptibility to obesity and insulin resistance. Gonadectomy studies indicated that gonadal hormones acting in a tissue-specific manner were responsible in part for the sex differences.
Asunto(s)
Enfermedades Cardiovasculares/metabolismo , Mitocondrias/metabolismo , Tejido Adiposo/metabolismo , Tejido Adiposo/patología , Animales , Enfermedades Cardiovasculares/patología , Femenino , Resistencia a la Insulina , Masculino , Ratones , Ratones Endogámicos , Ratones Transgénicos , Obesidad/metabolismo , Obesidad/patología , Fenotipo , Análisis de Componente Principal , Caracteres SexualesRESUMEN
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) encompasses benign steatosis and more severe conditions such as non-alcoholic steatohepatitis (NASH), cirrhosis, and liver cancer. This chronic liver disease has a poorly understood etiology and demonstrates sexual dimorphisms. We aim to examine the molecular mechanisms underlying sexual dimorphisms in NAFLD pathogenesis through a comprehensive multi-omics study. We integrated genomics (DNA variations), transcriptomics of liver and adipose tissue, and phenotypic data of NAFLD derived from female mice of ~ 100 strains included in the hybrid mouse diversity panel (HMDP) and compared the NAFLD molecular pathways and gene networks between sexes. RESULTS: We identified both shared and sex-specific biological processes for NAFLD. Adaptive immunity, branched chain amino acid metabolism, oxidative phosphorylation, and cell cycle/apoptosis were shared between sexes. Among the sex-specific pathways were vitamins and cofactors metabolism and ion channel transport for females, and phospholipid, lysophospholipid, and phosphatidylinositol metabolism and insulin signaling for males. Additionally, numerous lipid and insulin-related pathways and inflammatory processes in the adipose and liver tissue appeared to show more prominent association with NAFLD in male HMDP. Using data-driven network modeling, we identified plausible sex-specific and tissue-specific regulatory genes as well as those that are shared between sexes. These key regulators orchestrate the NAFLD pathways in a sex- and tissue-specific manner. Gonadectomy experiments support that sex hormones may partially underlie the sexually dimorphic genes and pathways involved in NAFLD. CONCLUSIONS: Our multi-omics integrative study reveals sex- and tissue-specific genes, processes, and networks underlying sexual dimorphism in NAFLD and may facilitate sex-specific precision medicine.
Asunto(s)
Tejido Adiposo/metabolismo , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/genética , Caracteres Sexuales , Animales , Castración , Femenino , Genómica , Metabolismo de los Lípidos , Masculino , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Transducción de Señal , TranscriptomaRESUMEN
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of global transcript levels in a population of inbred mouse strains showing variation for disease-related traits. This method has advantages such as controlled environment and accessibility to heart and plasma tissue in the preclinical selection stage. We illustrate the approach by identifying candidate heart failure (HF) biomarkers by overlaying mouse transcriptome and clinical traits from 91 Hybrid Mouse Diversity Panel (HMDP) inbred strains and human HF transcriptome from the Myocardial Applied Genomics Network (MAGNet) consortium. We found that some of the top differentially expressed genes correlated with known human HF biomarkers, such as galectin-3 and tissue inhibitor of metalloproteinase 1. Using ELISA assays, we investigated one novel candidate, Glycoprotein NMB, in a mouse model of chronic ß-adrenergic stimulation by isoproterenol (ISO) induced HF. We observed significantly lower GPNMB plasma levels in the ISO model compared to the control group (p-value = 0.007). In addition, we assessed GPNMB plasma levels among 389 HF cases and controls from the METabolic Syndrome In Men (METSIM) study. Lower levels of GPNMB were also observed in patients with HF from the METSIM study compared to non-HF controls (p-value < 0.0001). In summary, we have identified several candidate biomarkers for HF using the cardiac transcriptome data in a population of mice that may be directly relevant and applicable to human populations.
Asunto(s)
Proteínas del Ojo/metabolismo , Insuficiencia Cardíaca/genética , Insuficiencia Cardíaca/metabolismo , Glicoproteínas de Membrana/sangre , Glicoproteínas de Membrana/metabolismo , Anciano , Animales , Biomarcadores/metabolismo , Biología Computacional , Modelos Animales de Enfermedad , Femenino , Galectina 3/genética , Humanos , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Inhibidor Tisular de Metaloproteinasa-1/genética , TranscriptomaRESUMEN
We report the genetic analysis of a "humanized" hyperlipidemic mouse model for progressive nonalcoholic steatohepatitis (NASH) and fibrosis. Mice carrying transgenes for human apolipoprotein E*3-Leiden and cholesteryl ester transfer protein and fed a "Western" diet were studied on the genetic backgrounds of over 100 inbred mouse strains. The mice developed hepatic inflammation and fibrosis that was highly dependent on genetic background, with vast differences in the degree of fibrosis. Histological analysis showed features characteristic of human NASH, including macrovesicular steatosis, hepatocellular ballooning, inflammatory foci, and pericellular collagen deposition. Time course experiments indicated that while hepatic triglyceride levels increased steadily on the diet, hepatic fibrosis occurred at about 12 weeks. We found that the genetic variation predisposing to NASH and fibrosis differs markedly from that predisposing to simple steatosis, consistent with a multistep model in which distinct genetic factors are involved. Moreover, genome-wide association identified distinct genetic loci contributing to steatosis and NASH. Finally, we used hepatic expression data from the mouse panel and from 68 bariatric surgery patients with normal liver, steatosis, or NASH to identify enriched biological pathways. Conclusion: The pathways showed substantial overlap between our mouse model and the human disease.
Asunto(s)
Apolipoproteína E3/genética , Proteínas de Transferencia de Ésteres de Colesterol/genética , Modelos Animales de Enfermedad , Cirrosis Hepática/genética , Enfermedad del Hígado Graso no Alcohólico/genética , Aminoácidos/metabolismo , Animales , Colesterol/metabolismo , Grasas de la Dieta/efectos adversos , Ácidos Grasos/metabolismo , Femenino , Perfilación de la Expresión Génica , Estudio de Asociación del Genoma Completo , Humanos , Hiperlipidemias/complicaciones , Hígado/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones TransgénicosRESUMEN
Elevated hepatic ceramide levels have been implicated in both insulin resistance (IR) and hepatic steatosis. To understand the factors contributing to hepatic ceramide levels in mice of both sexes, we have quantitated ceramides in a reference population of mice, the Hybrid Mouse Diversity Panel that has been previously characterized for a variety of metabolic syndrome traits. We observed significant positive correlations between Cer(d18:1/16:0) and IR/hepatic steatosis, consistent with previous findings, although the relationship broke down between sexes, as females were less insulin resistant, but had higher Cer(d18:1/16:0) levels than males. The sex difference was due in part to testosterone-mediated repression of ceramide synthase 6. One ceramide species, Cer(d18:1/20:0), was present at higher levels in males and was associated with IR only in males. Clear evidence of gene-by-sex and gene-by-diet interactions was observed, including sex-specific genome-wide association study results. Thus, our studies show clear differences in how hepatic ceramides are regulated between the sexes, which again suggests that the physiological roles of certain hepatic ceramides differ between the sexes.
Asunto(s)
Ceramidas/metabolismo , Dieta , Resistencia a la Insulina/genética , Resistencia a la Insulina/fisiología , Hígado/metabolismo , Caracteres Sexuales , Animales , Ceramidas/biosíntesis , Femenino , Hígado/efectos de los fármacos , Masculino , Ratones , Testosterona/farmacologíaRESUMEN
The etiology of non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease, is poorly understood. To understand the causal mechanisms underlying NAFLD, we conducted a multi-omics, multi-tissue integrative study using the Hybrid Mouse Diversity Panel, consisting of â¼100 strains of mice with various degrees of NAFLD. We identified both tissue-specific biological processes and processes that were shared between adipose and liver tissues. We then used gene network modeling to predict candidate regulatory genes of these NAFLD processes, including Fasn, Thrsp, Pklr, and Chchd6. In vivo knockdown experiments of the candidate genes improved both steatosis and insulin resistance. Further in vitro testing demonstrated that downregulation of both Pklr and Chchd6 lowered mitochondrial respiration and led to a shift toward glycolytic metabolism, thus highlighting mitochondria dysfunction as a key mechanistic driver of NAFLD.
Asunto(s)
Enfermedad del Hígado Graso no Alcohólico/etiología , Enfermedad del Hígado Graso no Alcohólico/genética , Animales , Bases de Datos Genéticas , Perfilación de la Expresión Génica/métodos , Redes Reguladoras de Genes/genética , Genómica/métodos , Células HEK293 , Humanos , Resistencia a la Insulina , Metabolismo de los Lípidos , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos/genética , Mitocondrias/metabolismo , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Obesidad/metabolismo , Polimorfismo de Nucleótido Simple/genética , Proteómica/métodos , Proteínas Ribosómicas/genética , TranscriptomaRESUMEN
Iron homeostasis is tightly regulated, and the peptide hormone hepcidin is considered to be a principal regulator of iron metabolism. Previous studies in a limited number of mouse strains found equivocal sex- and strain-dependent differences in mRNA and serum levels of hepcidin and reported conflicting data on the relationship between hepcidin (Hamp1) mRNA levels and iron status. Our aim was to clarify the relationships between strain, sex, and hepcidin expression by examining multiple tissues and the effects of different dietary conditions in multiple inbred strains. Two studies were done: first, Hamp1 mRNA, liver iron, and plasma diferric transferrin levels were measured in 14 inbred strains on a control diet; and second, Hamp1 mRNA and plasma hepcidin levels in both sexes and iron levels in the heart, kidneys, liver, pancreas, and spleen in males were measured in nine inbred/recombinant inbred strains raised on an iron-sufficient or high-iron diet. Both sex and strain have a significant effect on both hepcidin mRNA (primarily a sex effect) and plasma hepcidin levels (primarily a strain effect). However, liver iron and diferric transferrin levels are not predictors of Hamp1 mRNA levels in mice fed iron-sufficient or high-iron diets, nor are the Hamp1 mRNA and plasma hepcidin levels good predictors of tissue iron levels, at least in males. We also measured plasma erythroferrone, performed RNA-sequencing analysis of liver samples from six inbred strains fed the iron-sufficient, low-iron, or high-iron diets, and explored differences in gene expression between the strains with the highest and lowest hepcidin levels.NEW & NOTEWORTHY Both sex and strain have a significant effect on both hepcidin mRNA (primarily a sex effect) and plasma hepcidin levels (primarily a strain effect). Liver iron and diferric transferrin levels are not predictors of Hamp1 mRNA levels in mice, nor are the Hamp1 mRNA and plasma hepcidin levels good predictors of tissue iron levels, at least in males.
Asunto(s)
Hepcidinas/biosíntesis , Hierro/metabolismo , ARN Mensajero/biosíntesis , Animales , Dieta , Femenino , Hepcidinas/genética , Hierro de la Dieta/farmacología , Masculino , Ratones , Ratones Endogámicos , Caracteres Sexuales , Especificidad de la Especie , Distribución Tisular , Transferrina/metabolismoRESUMEN
The etiology of nonalcoholic fatty liver disease is complex and influenced by factors such as obesity, insulin resistance, hyperlipidemia, and sex. We now report a study on sex difference in hepatic steatosis in the context of genetic variation using a population of inbred strains of mice. While male mice generally exhibited higher concentration of hepatic TG levels on a high-fat high-sucrose diet, sex differences showed extensive interaction with genetic variation. Differences in percentage body fat were the best predictor of hepatic steatosis among the strains and explained about 30% of the variation in both sexes. The difference in percent gonadal fat and HDL explained 9.6% and 6.7% of the difference in hepatic TGs between the sexes, respectively. Genome-wide association mapping of hepatic TG revealed some striking differences in genetic control of hepatic steatosis between females and males. Gonadectomy increased the hepatic TG to body fat percentage ratio among male, but not female, mice. Our data suggest that the difference between the sexes in hepatic TG can be partly explained by differences in body fat distribution, plasma HDL, and genetic regulation. Future studies are required to understand the molecular interactions between sex, genetics, and the environment.
Asunto(s)
Hígado Graso/genética , Lipoproteínas HDL/genética , Enfermedad del Hígado Graso no Alcohólico/genética , Obesidad/genética , Triglicéridos/genética , Animales , Dieta Alta en Grasa , Hígado Graso/sangre , Hígado Graso/patología , Femenino , Estudio de Asociación del Genoma Completo , Hormonas/genética , Hormonas/metabolismo , Hiperlipidemias/sangre , Hiperlipidemias/genética , Hiperlipidemias/patología , Resistencia a la Insulina/genética , Hígado/metabolismo , Hígado/patología , Masculino , Ratones , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/patología , Obesidad/sangre , Obesidad/patología , Polimorfismo de Nucleótido Simple/genética , Caracteres SexualesRESUMEN
The Hybrid Mouse Diversity Panel (HMDP) is a collection of approximately 100 well-characterized inbred strains of mice that can be used to analyze the genetic and environmental factors underlying complex traits. While not nearly as powerful for mapping genetic loci contributing to the traits as human genome-wide association studies, it has some important advantages. First, environmental factors can be controlled. Second, relevant tissues are accessible for global molecular phenotyping. Finally, because inbred strains are renewable, results from separate studies can be integrated. Thus far, the HMDP has been studied for traits relevant to obesity, diabetes, atherosclerosis, osteoporosis, heart failure, immune regulation, fatty liver disease, and host-gut microbiota interactions. High-throughput technologies have been used to examine the genomes, epigenomes, transcriptomes, proteomes, metabolomes, and microbiomes of the mice under various environmental conditions. All of the published data are available and can be readily used to formulate hypotheses about genes, pathways and interactions.
Asunto(s)
Enfermedades Cardiovasculares/genética , Modelos Animales de Enfermedad , Enfermedades Metabólicas/genética , Transcriptoma/genética , Animales , Aterosclerosis/genética , Enfermedades Cardiovasculares/patología , Estudio de Asociación del Genoma Completo , Insuficiencia Cardíaca/genética , Humanos , Hibridación Genética , Resistencia a la Insulina/genética , Enfermedades Metabólicas/patología , Ratones , Microbiota/genética , Obesidad/genética , Osteoporosis/genética , Sitios de Carácter Cuantitativo/genéticaRESUMEN
To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatty liver disease, we examined liver steatosis and related clinical and molecular traits in more than 100 unique inbred mouse strains, which were fed a diet rich in fat and carbohydrates. A >30-fold variation in hepatic TG accumulation was observed among the strains. Genome-wide association studies revealed three loci associated with hepatic TG accumulation. Utilizing transcriptomic data from the liver and adipose tissue, we identified several high-confidence candidate genes for hepatic steatosis, including Gde1, a glycerophosphodiester phosphodiesterase not previously implicated in triglyceride metabolism. We confirmed the role of Gde1 by in vivo hepatic over-expression and shRNA knockdown studies. We hypothesize that Gde1 expression increases TG production by contributing to the production of glycerol-3-phosphate. Our multi-level data, including transcript levels, metabolite levels, and gut microbiota composition, provide a framework for understanding genetic and environmental interactions underlying hepatic steatosis.
Asunto(s)
Estudio de Asociación del Genoma Completo , Enfermedad del Hígado Graso no Alcohólico/veterinaria , Hidrolasas Diéster Fosfóricas/genética , Enfermedades de los Roedores/genética , Tejido Adiposo/patología , Animales , Expresión Génica , Perfilación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Hígado/patología , Ratones Endogámicos , Enfermedad del Hígado Graso no Alcohólico/genética , Triglicéridos/metabolismoRESUMEN
OBJECTIVE: Inflammation of vascular smooth muscle cells (VSMC) is intimately linked to atherosclerosis and other vascular inflammatory disease. Thioredoxin interacting protein (Txnip) is a key regulator of cellular sulfhydryl redox and a mediator of inflammasome activation. The goals of the present study were to examine the impact of Txnip ablation on inflammatory response to oxidative stress in VSMC and to determine the effect of Txnip ablation on atherosclerosis in vivo. METHODS AND RESULTS: Using cultured VSMC, we showed that ablation of Txnip reduced cellular oxidative stress and increased protection from oxidative stress when challenged with oxidized phospholipids and hydrogen peroxide. Correspondingly, expression of inflammatory markers and adhesion molecules were diminished in both VSMC and macrophages from Txnip knockout mice. The blunted inflammatory response was associated with a decrease in NF-ĸB nuclear translocation. Loss of Txnip in VSMC also led to a dramatic reduction in macrophage adhesion to VSMC. In vivo data from Txnip-ApoE double knockout mice showed that Txnip ablation led to 49% reduction in atherosclerotic lesion in the aortic root and 71% reduction in the abdominal aorta, compared to control ApoE knockout mice. CONCLUSION: Our data show that Txnip plays an important role in oxidative inflammatory response and atherosclerotic lesion development in mice. The atheroprotective effect of Txnip ablation implicates that modulation of Txnip expression may serve as a potential target for intervention of atherosclerosis and inflammatory vascular disease.